{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:11:51Z","timestamp":1790187111111,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013988","name":"Dermira","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013988","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jaci.2022.01.028","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T19:58:19Z","timestamp":1646078299000},"page":"690-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Mechanistic insights into the antipruritic effects of lebrikizumab, an anti\u2013IL-13 mAb"],"prefix":"10.1016","volume":"150","author":[{"given":"Yannick","family":"Miron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Indersmitten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan A.","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferda","family":"Cevikbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10023","key":"10.1016\/j.jaci.2022.01.028_bib1","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2022.01.028_bib2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/dth.12032","article-title":"The effects of treatment on itch in atopic dermatitis","volume":"26","author":"Yarbrough","year":"2013","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaci.2022.01.028_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2019.06.016","article-title":"Pruritus in allergy and immunology","volume":"144","author":"Yang","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.01.028_bib4","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/exd.13911","article-title":"Understanding the immune landscape in atopic dermatitis: the era of biologics and emerging therapeutic approaches","volume":"28","author":"Moyle","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2022.01.028_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5021\/ad.2010.22.2.125","article-title":"Atopic dermatitis","volume":"22","author":"Bieber","year":"2010","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaci.2022.01.028_bib6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaci.2013.10.048","article-title":"A sensory neuron\u2013expressed IL-31 receptor mediates T helper cell\u2013dependent itch: involvement of TRPV1 and TRPA1","volume":"133","author":"Cevikbas","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.01.028_bib7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ni1084","article-title":"Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice","volume":"5","author":"Dillon","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2022.01.028_bib8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jaci.2017.10.045","article-title":"IL-31: a new key player in dermatology and beyond","volume":"141","author":"Ba\u011fci","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.01.028_bib9","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jaci.2018.03.018","article-title":"Nemolizumab in patients with moderate-to-severe atopic dermatitis: randomized, phase II, long-term extension study","volume":"142","author":"Kabashima","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.01.028_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","article-title":"Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch","volume":"171","author":"Oetjen","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2022.01.028_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coi.2018.05.005","article-title":"Cytokine modulation of atopic itch","volume":"54","author":"Trier","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2022.01.028_bib12","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/exd.14034","article-title":"Interleukin-4 and interleukin-13 evoke scratching behaviour in mice","volume":"28","author":"Campion","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2022.01.028_bib13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jamadermatol.2020.0079","article-title":"Efficacy and safety of lebrikizumab, a hgh-affinity interleukin 13 inhibitor, in adults with moderate to severe atopic dermatitis: a phase 2b randomized clinical trial","volume":"156","author":"Guttman-Yassky","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2022.01.028_bib14","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.pain.2014.06.017","article-title":"Human sensory neurons: membrane properties and sensitization by inflammatory mediators","volume":"155","author":"Davidson","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.jaci.2022.01.028_bib15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1471-2105-15-182","article-title":"Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads","volume":"15","author":"Jiang","year":"2014","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jaci.2022.01.028_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-Seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaci.2022.01.028_bib17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation","volume":"28","author":"Trapnell","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jaci.2022.01.028_bib18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nbt.2450","article-title":"Differential analysis of gene regulation at transcript resolution with RNA-Seq","volume":"31","author":"Trapnell","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"W1","key":"10.1016\/j.jaci.2022.01.028_bib19","doi-asserted-by":"crossref","first-page":"W83","DOI":"10.1093\/nar\/gkw199","article-title":"Profiler\u2014a web server for functional interpretation of gene lists (2016 update)","volume":"44","author":"Reimand","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2022.01.028_bib20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1152\/physrev.00052.2017","article-title":"The role of voltage-gated sodium channels in pain signaling","volume":"99","author":"Bennett","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jaci.2022.01.028_bib21","first-page":"97","article-title":"Pathogenesis of atopic dermatitis: current paradigm","volume":"16","author":"Furue","year":"2019","journal-title":"Iran J Immunol"},{"key":"10.1016\/j.jaci.2022.01.028_bib22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2340\/00015555-1428","article-title":"Association of nerve growth factor, chemokine (C-C motif) ligands and immunoglobulin E with pruritus in cutaneous T-cell lymphoma","volume":"93","author":"Suga","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2022.01.028_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jdermsci.2013.04.011","article-title":"The chemokine receptor CCR3 participates in tissue remodeling during atopic skin inflammation","volume":"71","author":"Gaspar","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2022.01.028_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000100895","article-title":"Modulation of chemokines by staphylococcal superantigen in atopic dermatitis","volume":"93","author":"Homey","year":"2007","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.jaci.2022.01.028_bib25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jaci.2006.03.047","article-title":"Cytokines and chemokines orchestrate atopic skin inflammation","volume":"118","author":"Homey","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.01.028_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2249.2005.02875.x","article-title":"Interleukin-4 and interleukin-13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells","volume":"141","author":"Kagami","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2022.01.028_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.576967","article-title":"CCL26 and CCR3 are associated with the acute inflammatory response in the CNS in experimental autoimmune encephalomyelitis","volume":"333","author":"Shou","year":"2019","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jaci.2022.01.028_bib28","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jaci.2019.07.013","article-title":"Oral Janus kinase\/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis","volume":"144","author":"Pavel","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.01.028_bib29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s11882-007-0051-x","article-title":"IL-13 receptor isoforms: breaking through the complexity","volume":"7","author":"Tabata","year":"2007","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2022.01.028_bib30","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.3390\/ijms20133324","article-title":"Scratching counteracts IL-13 signaling by upregulating the decoy receptor IL-13R\u03b12 in keratinocytes","volume":"20","author":"Ulzii","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"6135","key":"10.1016\/j.jaci.2022.01.028_bib31","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1126\/science.1233765","article-title":"The cells and circuitry for itch responses in mice","volume":"340","author":"Mishra","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jaci.2022.01.028_bib32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.15252\/embr.201540983","article-title":"A subpopulation of itch-sensing neurons marked by Ret and somatostatin expression","volume":"17","author":"Stantcheva","year":"2016","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jaci.2022.01.028_bib33","doi-asserted-by":"crossref","first-page":"10888","DOI":"10.1038\/s41598-019-47267-5","article-title":"BAM8-22 and its receptor MRGPRX1 may attribute to cholestatic pruritus","volume":"9","author":"Sanjel","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2022.01.028_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaci.2016.12.980","article-title":"Substance P activates Mas-related G protein\u2013coupled receptors to induce itch","volume":"140","author":"Azimi","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.01.028_bib35","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1152\/physrev.00017.2019","article-title":"Physiology and pathophysiology of itch","volume":"100","author":"Cevikbas","year":"2020","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jaci.2022.01.028_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036355","article-title":"CGRP\u03b1-expressing sensory neurons respond to stimuli that evoke sensations of pain and itch","volume":"7","author":"McCoy","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2022.01.028_bib37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nn.2789","article-title":"TRPA1 is required for histamine-independent, Mas-related G protein\u2013coupled receptor\u2013mediated itch","volume":"14","author":"Wilson","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jaci.2022.01.028_bib38","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1586\/ern.10.154","article-title":"Nerve growth factor, pain, itch and inflammation: lessons from congenital insensitivity to pain with anhidrosis","volume":"10","author":"Indo","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.jaci.2022.01.028_bib39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11912-019-0761-y","article-title":"TRK inhibitors: clinical development of larotrectinib","volume":"21","author":"Bhangoo","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.jaci.2022.01.028_bib40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/0063030-200822060-00002","article-title":"Targeting nerve growth factor in pain: what is the therapeutic potential?","volume":"22","author":"Watson","year":"2008","journal-title":"BioDrugs"},{"key":"10.1016\/j.jaci.2022.01.028_bib41","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1097\/j.pain.0000000000000980","article-title":"Nonhistaminergic and mechanical itch sensitization in atopic dermatitis","volume":"158","author":"Andersen","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.jaci.2022.01.028_bib42","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1080\/14656566.2020.1775815","article-title":"Current and emerging systemic treatments targeting the neural system for chronic pruritus","volume":"21","author":"Golpanian","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaci.2022.01.028_bib43","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1097\/j.pain.0000000000001678","article-title":"Itch sensitization? A\u00a0systematic review of studies using quantitative sensory testing in patients with chronic itch","volume":"160","author":"van Laarhoven","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.jaci.2022.01.028_bib44","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaci.2016.02.020","article-title":"The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves","volume":"138","author":"Feld","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.01.028_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/all.13239","article-title":"Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis","volume":"73","author":"Furue","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.01.028_bib46","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/jdv.13794","article-title":"Interleukin (IL) 31 induces in cynomolgus monkeys a rapid and intense itch response that can be inhibited by an IL-31 neutralizing antibody","volume":"31","author":"Lewis","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2022.01.028_bib47","doi-asserted-by":"crossref","first-page":"17797","DOI":"10.1038\/s41598-017-18187-z","article-title":"Increased plasma IL-17, IL-31, and IL-33 levels in chronic spontaneous urticaria","volume":"7","author":"Lin","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2022.01.028_bib48","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jaci.2019.06.031","article-title":"Selective role of neurokinin B in IL-31\u2013induced itch response in mice","volume":"144","author":"Sakata","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.01.028_bib49","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00403-004-0455-6","article-title":"Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis","volume":"295","author":"Tazawa","year":"2004","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaci.2022.01.028_bib50","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pain.2006.06.003","article-title":"Bradykinin is a potent pruritogen in atopic dermatitis: a switch from pain to itch","volume":"126","author":"Hosogi","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.jaci.2022.01.028_bib51","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1212\/WNL.62.2.212","article-title":"Painful stimuli evoke itch in patients with chronic pruritus: central sensitization for itch","volume":"62","author":"Ikoma","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jaci.2022.01.028_bib52","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/mi.2014.109","article-title":"Neurotrophic tyrosine kinase receptor 1 is a direct transcriptional and epigenetic target of IL-13 involved in allergic inflammation","volume":"8","author":"Rochman","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2022.01.028_bib53","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cyto.2003.08.006","article-title":"The negative-feedback regulation of the IL-13 signal by the IL-13 receptor alpha2 chain in bronchial epithelial cells","volume":"24","author":"Yasunaga","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2022.01.028_bib54","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4049\/jimmunol.180.1.522","article-title":"IL-13 receptor alpha2 selectively inhibits IL-13\u2013induced responses in the murine lung","volume":"180","author":"Zheng","year":"2008","journal-title":"J Immunol"},{"issue":"pt A","key":"10.1016\/j.jaci.2022.01.028_bib55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuropharm.2014.10.027","article-title":"Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability","volume":"96","author":"Vezzani","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jaci.2022.01.028_bib56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nn.3881","article-title":"Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing","volume":"18","author":"Usoskin","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jaci.2022.01.028_bib57","first-page":"1131","article-title":"Itch-associated neuropeptides and their receptor expression in dog dorsal root ganglia and spinal cord","volume":"99","author":"Wheeler","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2022.01.028_bib58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaci.2018.05.008","article-title":"Epithelial origin of eosinophilic esophagitis","volume":"142","author":"Rochman","year":"2018","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922002330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922002330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:39:15Z","timestamp":1758793155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674922002330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0091674922002330"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2022.01.028","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic insights into the antipruritic effects of lebrikizumab, an anti\u2013IL-13 mAb","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2022.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}